(Q42510602)

1 November 2017

Chemically induced mouse models of intestinal inflammation (English)

1 reference

1 November 2017

0 references

1

1 reference

1 November 2017

3

Benno Weigmann

1 reference

1 November 2017

4

Markus F Neurath

1 reference

1 November 2017

2

Clemens Neufert

1 reference

1 November 2017

1 January 2007

1 reference

1 November 2017

1 reference

1 November 2017

2

1 reference

1 November 2017

541-546

1 reference

1 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nprot.2007.41

1 November 2017

0 references

cites work

Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Antibodies to interleukin 12 abrogate established experimental colitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Oxazolone-induced colitis in rats: effects of budesonide, cyclosporin A, and 5-aminosalicylic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

High resolution colonoscopy in live mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.41

31 March 2020

Identifiers

DOI

10.1038/NPROT.2007.41

1 reference

1 November 2017

1 reference

PubMed ID

17406617